Most US neurologists prescribing MS drugs have received pharma industry cash

Higher volume prescribers more likely to receive payments; and recipients more likely to prescribe that company’s drugs, especially if payments were larger, sustained, and recent Nearly 80% of US neurologists prescribing drugs for multiple sclerosis (MS) received at least one pharma industry payment, with higher volume prescribers more likely to ...

2025-08-26T10:41:57+00:0026 August 2025|BMJ Open, Press release|

Companies may be misleading parents with “outrageous claims” about banking baby teeth

Experts alarmed by “outrageous” treatment claims for autism and diabetes Several claims to be reviewed by Advertising Standards Agency Parents are spending thousands of pounds to bank stem cells from their children’s milk teeth – but the recipient companies’ claims about their future medical value are unproven and potentially misleading, ...

2025-08-26T10:24:27+00:0026 August 2025|Press release, The BMJ|

Medical pros of electroconvulsive therapy (ECT) exaggerated while cons downplayed, survey findings suggest

Patients nearly 4 times more likely to recall being told of short rather than long-term memory loss and 6 times more likely to recall being told ECT can be life saving rather than about potential heart problems The medical pros of electroconvulsive therapy (ECT) are being exaggerated while the risks ...

2025-08-20T12:17:44+00:0020 August 2025|Journal of Medical Ethics, Press release|

Experts recommend SGLT-2 and GLP-1 diabetes drugs only for adults at moderate to higher risk of heart and kidney problems

Recommendations account for varied patient risk profiles and focus on weight loss effects, particularly of drugs of interest to adults with concomitant obesity SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher risk of cardiovascular and kidney ...

2025-08-15T14:49:00+00:0015 August 2025|Press release, The BMJ|

ADHD medication linked to reduced risk of suicide, drug abuse, transport accidents and criminal behaviour

Findings should help inform clinical practice and the debate on ADHD drug treatment Drug treatment for people with newly diagnosed attention deficit hyperactivity disorder (ADHD) is associated with significantly reduced risks of suicidal behaviours, substance misuse, transport accidents, and criminality, finds a study published by The BMJ today. The researchers say this ...

2025-08-14T10:53:39+00:0014 August 2025|Press release, The BMJ|

GLP-1 diabetes drugs likely trump metformin for curbing dementia risk in type 2 diabetes

Findings suggest future guidelines prioritise drugs with dual blood glucose and neuroprotective effects GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of its kind, published in ...

Near tripling in US reported lidocaine local anaesthetic poisonings/deaths over past decade

Amid substantial fall in reports associated with other local anaesthetics Poisonings and deaths linked to the use of the local anaesthetic lidocaine have nearly tripled in the US over the past decade, finds an analysis of National Poison Data System (NPDS) reports, published online in the journal Regional Anesthesia & Pain ...

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Six or more prescriptions associated with, respectively, 29% and 85% heightened risks And risks more than doubled in 18-64 year olds, shows large medical record study Receiving six or more prescriptions of the drug gabapentin for low back pain is associated with significantly increased risks of developing dementia and mild ...

Surgery plus speech therapy linked to improved language after stroke

Trial suggests this is a superior treatment for chronic post-stroke aphasia Combining neck surgery with intensive speech therapy is associated with greater improvements in a person's ability to communicate after a stroke than intensive speech therapy alone, finds a clinical trial published by The BMJ today. The results show improvements immediately after ...

2025-06-26T09:16:11+00:0026 June 2025|Press release, The BMJ|
Go to Top